Abcam has completed a $340m strategic acquisition of BioVision and doubled the footprint of its immunoassay kit R&D and manufacturing facility in Eugene, Oregon. This enhanced capacity is another component of Abcam’s growth in the US, which the company says will enable it to support the research and biopharma… Read More
Professor Paul Whiting, Chief Scientific Officer of The Alzheimer’s Research UK UCL Drug Discovery Institute (ARUK UCL DDI), and Stephane Martinez, product manager and neuroscience expert in PerkinElmer’s Life Sciences segment, share expert insights on Alzheimer’s Disease research today and where discovery and therapeutic approaches might be headed next. Read More
A group of researchers led by Indiana University School of Medicine’s Benjamin Gaston has been awarded a research programme project grant from the National Heart, Lung and Blood Institute. The award amounts to just over $12 million over the next five years and will fund the development of personalised… Read More
Ahead of COP26, which began on October 31 in Glasgow and runs until November 12, the Association of the British Pharmaceutical Industry (ABPI) led a joint statement from the pharmaceutical industry alongside other global associations. Organisations included in the statement were: The European Federation of Pharmaceutical Industries… Read More
Ubiquigent will provide Bristol Myers Squibb with increased access to its deubiquitylase (DUB) enzyme inhibitor drug discovery platform to provide support to therapeutic areas, in an extension of the companies’ long-term collaboration. Ubiquitylation in diverse cellular processes, including but not limited to protein degradation, makes the enzymes responsible for ubiquitylation… Read More
Genetic Analysis has announced a Service Agreement with Eurofins ADME Bioanalysis, a CRO who have launched a standardised gut microbiome test (GA-map Dysbiosis Test). Gut microbiome profiling is required as a surrogate endpoint or exploratory biomarker in clinical trials. This is due to both the impact new pharmaceuticals can… Read More
MOBILion Systems will showcase its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, at the 69th Annual American Society for Mass Spectrometry (ASMS) conference. Taking place from October 31 to November 4, the conference is the first in-person ASMS since 2019 and is being held in Philadelphia. Read More
Listen to this article on the DDW Podcast: Panna Sharma is the President and CEO of Lantern Pharma, a clinical-stage oncology biotech using AI and genomics to innovate the rescue, revitalisation, and development of precision cancer therapeutics. Lu Rahman spoke to the man behind this biotech to find out why he… Read More
Doina Ionescu, General Manager for the UK & Ireland at Merck, talks with DDW’s Megan Thomas about Merck’s innovations in the oncology sector, her thoughts on the future opportunities in the sector, as well some trade secrets and more. MT: The company has expertise in the oncology space – what innovations can… Read More
Moderna has announced positive interim data from its Phase II/III study (KidCOVE) of mRNA-1273, the company’s vaccine candidate against Covid-19, in children six to 12 years of age. This interim analysis showed a robust neutralising antibody response after two doses of mRNA-1273 at the 50µg dose level with a favourable… Read More
The Medicines Patent Pool (MPP), the World Health Organization (WHO), Afrigen Biologics, the Biologicals and Vaccines Institute of Southern Africa (Biovac), the South African Medical Research Council (SAMRC), and Africa Centres for Disease Control and Prevention (Africa CDC) have signed a letter of intent to address the global… Read More
DNA Script has raised $165 million in a Series C financing led by Coatue Management and Catalio Capital Management, whose representatives have joined as board observers. The new funds will be used to accelerate expansion and commercialisation of the company’s SYNTAX Platform and broaden the portfolio of products powered by EDS. DNA Script… Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW's Market Report, Sy Chyi Yeoh, Director of Business Development at global regulatory service provider ELC Group, explains why the biotech sector in China is worth watching and offers advice for those keen to take advantage. … Read More
Within our drug discovery world, unless we have contact with clinical settings, it is easy to lose sight that our expertise, time, laboratory instruments, software, reagents, tools, workflows and procedures etc. are ultimately designed for the benefit of real-life patients. Deriving Context from Immunological Data with Advanced Flow Cytometry… Read More
Listen to this article on the DDW Podcast: Dr Tomasz Kostrzewski, Director of Biology at CN Bio Innovations, examines MPS in drug discovery as part of a preclinical toolbox. Drug development remains slow and costly for the pharmaceutical industry, driven by the financial impact of late-stage failures of drug candidates1. Although… Read More
News round-up by DDW’s Megan Thomas for 25-29 October DDW’s Megan Thomas has selected five stories which highlight the results that can be achieved through collaboration in the drug discovery sector. 1. Australian researchers identify new pathways to target breast cancer A… Read More
